New Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

New Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$44K	Hold	705	–	–	0.04%	68
2020 Q4	$44K	Hold	705	–	–	0.02%	69
2020 Q3	$42K	Hold	705	–	–	0.05%	65
2020 Q2	$41K	Hold	705	–	–	0.06%	61
2020 Q1	$39K	Sell	705 -257	-27%	-$15.7K	0.07%	50
2019 Q4	$62K	Hold	962	–	–	0.1%	51
2019 Q3	$49K	Buy	962 +2	+0.2%	+$94	0.04%	56
2019 Q2	$44K	Buy	960 +2	+0.2%	+$93	0.08%	60
2019 Q1	$46K	Buy	958 +2	+0.2%	+$100	0.13%	56
2018 Q4	$50K	Sell	956 -183	-16%	-$9.83K	0.09%	50
2018 Q3	$71K	Buy	1,139 +187	+20%	+$11.1K	0.12%	51
2018 Q2	$53K	Buy	952 +2	+0.2%	+$108	0.09%	58
2018 Q1	$60K	Buy	950 +1	+0.1%	+$64	0.16%	58
2017 Q4	$58K	Buy	949 +3	+0.3%	+$188	0.07%	62
2017 Q3	$60K	Buy	946 +260	+38%	+$15.2K	0.11%	58
2017 Q2	$37K	Hold	686	–	–	0.07%	80
2017 Q1	$37K	Buy	686 +2	+0.3%	+$110	0.07%	80
2016 Q4	$40K	Buy	+684	New	+$37.4K	0.06%	72

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

New Capital Management's BMY Position: Q1 2021 in Review

New Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2021 at 705 shares worth $44K. The position accounts for 0.04% of the portfolio, ranked #68.

New Capital Management first reported a position in BMY in Q4 2016 and has held it in 18 quarters since. The position peaked at $71K in Q3 2018. 2,370 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

New Capital Management held 705 shares of Bristol-Myers Squibb worth $44K as of Q1 2021.
New Capital Management left its Bristol-Myers Squibb share count unchanged in Q1 2021.
Bristol-Myers Squibb made up 0.04% of New Capital Management's portfolio in Q1 2021, its #68 holding.
New Capital Management first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 18 quarters since.
New Capital Management's Bristol-Myers Squibb position peaked at $71K in Q3 2018.
2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on New Capital Management's 13F filing for Q1 2021, filed 15 Apr 2021.